Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: A systematic review

被引:445
|
作者
Boonstra, Kirsten [1 ]
Beuers, Ulrich [1 ]
Ponsioen, Cyriel Y. [1 ]
机构
[1] Acad Med Ctr, Dept Gastroenterol & Hepatol, NL-1100 DD Amsterdam, Netherlands
关键词
Primary sclerosing cholangitis; Primary biliary cirrhosis; Epidemiology; Incidence; Prevalence; POPULATION-BASED COHORT; URSODEOXYCHOLIC ACID; NATURAL-HISTORY; DEFINED POPULATION; CLINICAL-FEATURES; PREVALENCE; COMMUNITY; SWEDEN; CHOLANGIOGRAPHY; AUSTRALIA;
D O I
10.1016/j.jhep.2011.10.025
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Objective: Studies on the epidemiology of primary sclerosing cholangitis (PSC) and primary biliary cirrhosis (PBC) show variable outcome. We aimed at systematically reviewing the incidence and prevalence rates, as well as geographical distribution and temporal trends of PSC and PBC. Data sources: A systematic search of literature was performed in Medline and EMBASE (search last conducted January 10th, 2011). Study selection: Population-based epidemiological studies reporting incidence and/or prevalence rates for PSC or PBC in a defined geographical area of at least 100,000 adult inhabitants were considered relevant. Data extraction: Study area, study period, number of patients, number of inhabitants, incidence per 100,000 inhabitants per year, prevalence per 100,000 inhabitants, method of case-finding, method of case-ascertainment, male/female ratio and in case of PSC, occurrence of inflammatory bowel diseases (IBD) were extracted from retrieved articles. Results: The literature search yielded 2286 abstracts of which 31 articles fulfilled all inclusion criteria. Studies varied in size from 10 to 770 patients in catchment areas from 100,312 to 19,230,000 inhabitants. The incidence and prevalence rates for PSC range from 0 to 1.3 per 100,000 inhabitants/year and 0-16.2 per 100,000 inhabitants, respectively. PBC incidence rates range from 0.33 to 5.8 per 100,000 inhabitants/year and prevalence rates range from 1.91 to 40.2 per 100,000 inhabitants; prevalence rates are increasing in time. Conclusions: Incidence and prevalence rates of both PSC and PBC vary widely and seem to be increasing. True population-based studies are scarce and therefore large population-based studies combining meticulous case-finding and case-ascertainment strategies are necessary. (C) 2012 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:1181 / 1188
页数:8
相关论文
共 50 条
  • [1] Primary Sclerosing Cholangitis and Primary Biliary Cirrhosis Overlap Syndrome: A Review
    Mago, Sheena
    Wu, George Y.
    JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 2020, 8 (03) : 336 - 346
  • [2] The epidemiology and natural history of primary biliary cirrhosis: a nationwide population-based study
    Baldursdottir, Theodora R.
    Bergmann, Ottar M.
    Jonasson, Jon G.
    Ludviksson, Bjorn R.
    Axelsson, Tomas A.
    Bjornsson, Einar S.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2012, 24 (07) : 824 - 830
  • [3] Regional variation and temporal trend of primary biliary cholangitis epidemiology: A systematic review and meta-analysis
    Lv, Tingting
    Chen, Sha
    Li, Min
    Zhang, Dong
    Kong, Yuanyuan
    Jia, Jidong
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 (06) : 1423 - 1434
  • [4] Epidemiology, Natural History, and Outcomes of Primary Sclerosing Cholangitis: A Systematic Review of Population-based Studies
    Trivedi, Palak J.
    Bowlus, Christopher L.
    Yimam, Kidist K.
    Razavi, Homie
    Estes, Chris
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2022, 20 (08) : 1687 - +
  • [5] The Immunophysiology and Apoptosis of Biliary Epithelial Cells: Primary Biliary Cirrhosis and Primary Sclerosing Cholangitis
    Kawata, Kazuhito
    Kobayashi, Yoshimasa
    Gershwin, M. Eric
    Bowlus, Christopher L.
    CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2012, 43 (03) : 230 - 241
  • [6] Treatment options for primary biliary cirrhosis and primary sclerosing cholangitis
    Cynthia Levy
    Keith D. Lindor
    Current Treatment Options in Gastroenterology, 2003, 6 (2) : 93 - 103
  • [7] Surgical treatment of primary biliary cirrhosis and primary sclerosing cholangitis
    Loehe, F
    Schauer, RJ
    CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2005, 28 (02) : 167 - 174
  • [8] Animal Models in Primary Biliary Cirrhosis and Primary Sclerosing Cholangitis
    Marion J. Pollheimer
    Peter Fickert
    Clinical Reviews in Allergy & Immunology, 2015, 48 : 207 - 217
  • [9] Surgical treatment of primary biliary cirrhosis and primary sclerosing cholangitis
    Florian Loehe
    Rolf J. Schauer
    Clinical Reviews in Allergy & Immunology, 2005, 28 : 167 - 174
  • [10] Medical treatment of primary biliary cirrhosis and primary sclerosing cholangitis
    Holtmeier, J
    Leuschner, U
    DIGESTION, 2001, 64 (03) : 137 - 150